Portfolio (Quarterly)
Guide ↗
Mirae Asset Global Investments Co., Ltd.
· CIK 0001569395| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1301 | MPT | MEDICAL PROPERTIES TRUST INC | Financial Services | 10,579.0 | $49K | — | -4K | -29.4% | $4.63 | +4.8% |
| 1302 | IVT | INVENTRUST PPTYS CORP | Real Estate | 1,599.0 | $49K | — | -670.0 | -29.5% | $30.46 | +13.3% |
| 1303 | HIW | HIGHWOODS PPTYS INC | Real Estate | 2,262.0 | $48K | — | -897.0 | -28.4% | $21.41 | +37.6% |
| 1304 | NTNX | NUTANIX INC | Technology | 1,261.0 | $48K | — | -5K | -81.2% | $38.01 | +27.1% |
| 1305 | PCRX | PACIRA BIOSCIENCES INC | Healthcare | 2,112.0 | $48K | — | +21.0 | +1.0% | $22.60 | +1.0% |
| 1306 | ELF | E L F BEAUTY INC | Consumer Defensive | 776.0 | $47K | — | -200.0 | -20.5% | $60.61 | +10.4% |
| 1307 | — | HENNESSY CAP INVT CORP VII | — | 4,500.0 | $47K | — | -46K | -91.0% | $10.35 | — |
| 1308 | AMPH | AMPHASTAR PHARMACEUTICALS IN | Healthcare | 2,366.0 | $46K | — | +133.0 | +6.0% | $19.59 | +1.9% |
| 1309 | LINE | LINEAGE INC | Real Estate | 1,410.0 | $46K | — | -595.0 | -29.7% | $32.76 | +30.7% |
| 1310 | XNCR | XENCOR INC | Healthcare | 3,825.0 | $46K | — | +355.0 | +10.2% | $12.06 | +1.2% |
| 1311 | FTRE | FORTREA HLDGS INC | Healthcare | 4,877.0 | $46K | — | +387.0 | +8.6% | $9.42 | +69.6% |
| 1312 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 4,110.0 | $46K | — | +653.0 | +18.9% | $11.11 | -6.1% |
| 1313 | GHRS | GH RESEARCH PLC | Healthcare | 3,235.0 | $45K | — | +221.0 | +7.3% | $14.06 | +42.1% |
| 1314 | RNG | RINGCENTRAL INC | Technology | 1,214.0 | $45K | — | -5K | -81.3% | $37.19 | +2.3% |
| 1315 | ABUS | ARBUTUS BIOPHARMA CORP | Healthcare | 10,032.0 | $45K | — | +686.0 | +7.3% | $4.50 | -2.4% |
| 1316 | CRBG | COREBRIDGE FINL INC | Financial Services | 1,869.0 | $45K | — | +41.0 | +2.2% | $23.86 | +22.4% |
| 1317 | KTB | KONTOOR BRANDS INC | Consumer Cyclical | 630.0 | $44K | — | NEW | — | $70.29 | +10.2% |
| 1318 | JANX | JANUX THERAPEUTICS INC | Healthcare | 3,173.0 | $44K | — | +250.0 | +8.6% | $13.90 | -1.4% |
| 1319 | URGN | UROGEN PHARMA LTD | Healthcare | 2,442.0 | $44K | — | +167.0 | +7.3% | $17.98 | +71.7% |
| 1320 | CGEM | CULLINAN THERAPEUTICS INC | Healthcare | 3,081.0 | $44K | — | +210.0 | +7.3% | $14.21 | -4.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
41.2%
Communication Services
12.3%
Consumer Cyclical
10.0%
Healthcare
8.1%
Financial Services
7.7%
Industrials
6.8%
Consumer Defensive
5.9%
Energy
3.6%
Utilities
2.1%
Basic Materials
1.2%